CLINICAL_TRIALS
research
· 2026-04-13
Clinical Trial Update: Spironolactone Alternate Dosing vs Finerenone in Elevated Potassium - K Safety Study [Phase 4]
Summary
A Phase 4 trial comparing alternate dosing of spironolactone versus finerenone to evaluate safety in patients with elevated potassium related to heart failure a…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hospital de Messejana Dr. Carlos Alberto Studart Gomes | Conditions: Heart Failure, Diabetic Kidney Disease | Phase 4 | Status: NOT_YET_RECRUITING